<DOC>
	<DOC>NCT00265551</DOC>
	<brief_summary>The purpose of this study is to determine whether a low dose and a high dose of the study drug SCA-136 are effective and safe in the treatment of schizophrenia requiring hospitalization.</brief_summary>
	<brief_title>Study Evaluating SCA-136 in Subjects With Acute Exacerbations of Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Clinical diagnosis of schizophrenia Ability to remain hospitalized for at least first 4 weeks of study Needs hospitalization due to worsening of schizophrenia Type 1 or 2 diabetes Previous use of clozapine Serious medical illness other than schizophrenia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Schizophrenia</keyword>
</DOC>